Search Results - Gullie, Jude

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Recapturing disease response: A phase 2 study of carfilzomib 56mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27mg/m2

    Recapturing disease response: A phase 2 study of carfilzomib 56mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27mg/m2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J, Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Gillian Morgan Sanchez, Catamero, Donna, Verina, Daniel, Florendo, Erika, Moon‐hee Yum, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J., Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Sanchez, Gillian Morgan, Catamero, Donna, Verina, Daniel, Florendo, Erika, Yum, Moon‐hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m 2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m 2

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m 2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m 2 by Barley, Kevin, Sanchez, Larysa, Cho, Hearn J, Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Sanchez, Gillian Morgan, Catamero, Donna, Verina, Daniel, Florendo, Erika, Yum, Moon-Hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib

    Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib by Chari, Ajai, Cho, Hearn Jay, Parekh, Samir, Osman, Keren, Goldstein, Talia, Morgan, Gillian, La, Lisa, Carter, Crystle, Catamero, Donna, Escalon, Juliet, Verina, Daniel, Florendo, Erika, Yum, Moon-hee, Stevens, Nadege, Gullie, Jude, Chan, Elaine, Jagannath, Sundar

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma

    A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma by Chari, Ajai, Cho, Hearn J., Parekh, Samir, Dhadiwal, Amishi, Garcia, Katarzyna, Belostotsky, Natalie, Catamero, Donna, Brion, Arlynn, Cardone, Lauren, Escalaon, Juliet, Verina, Daniel, Yum, Moon-hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma

    A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma by Biran, Noa, Shahnaz, Samira, Jagannath, Sundar, Cho, Hearn J., Osman, Keren, Parekh, Samir, Choi, Danielle, Garcia, Katarzyna, Catamero, Donna, La, Lisa, Gullie, Jude, Chan, Elaine, Chari, Ajai

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

    A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma by Chari, Ajai, Cho, Hearn Jay, Leng, Siyang, Dhadwal, Amishi, Morgan, Gillian, La, Lisa, Garcia, Katarzyna, Carter, Crystle, Catamero, Donna, Escalon, Juliet, Florendo, Erika, Stevens, Nadege, Verina, Daniel, Yum, Moon-hee, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Leshchenko, Violetta V, Lagana, Alessandro, Qi, Jingjing, Patel, Manishkumar, Seunghee, Kim-Schulze, Parekh, Samir

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: